Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

K. Briscoe · SciRah

Researcher profile · Semantic Scholar

K. Briscoe

Share profile

K. Briscoe — researcher profile on SciRah

h-index: 16
Works: 42
Citations: 1,501

Most-cited papers

Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial.
V. Galimberti, B. Cole, G. Viale, P. Veronesi +196 more
2018The Lancet Oncology499 citations Open access
Semantic Scholar
Nivolumab for Patients With Advanced Melanoma Treated Beyond Progression: Analysis of 2 Phase 3 Clinical Trials
Georgina V. Long, J. Weber, J. Larkin, V. Atkinson +11 more
2017JAMA Oncology163 citations Open access
Semantic Scholar
Durvalumab with first-line chemotherapy in previously untreated malignant pleural mesothelioma (DREAM): a multicentre, single-arm, phase 2 trial with a safety run-in.
A. Nowak, W. Lesterhuis, Peey-Sei Kok, Chris Brown +14 more
2020The Lancet Oncology143 citations Open access
Semantic Scholar
Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting (CINV): a randomised, placebo-controlled, phase 2 crossover trial.
P. Grimison, Antony J. Mersiades, Adrienne Kirby, N. Lintzeris +19 more
2020Annals of Oncology121 citations Open access
Semantic Scholar
Toxic Epidermal Necrolysis–like Reaction With Severe Satellite Cell Necrosis Associated With Nivolumab in a Patient With Ipilimumab Refractory Metastatic Melanoma
N. Nayar, K. Briscoe, P. Fernández-Peñas
2016Journal of immunotherapy101 citations
Semantic Scholar
A distinct plasma lipid signature associated with poor prognosis in castration‐resistant prostate cancer
Hui-Ming Lin, K. Mahon, J. Weir, P. Mundra +12 more
2017International Journal of Cancer78 citations Open access
Semantic Scholar
Phase 2 study of circulating microRNA biomarkers in castration-resistant prostate cancer
Hui-Ming Lin, K. Mahon, C. Spielman, H. Gurney +7 more
2017British Journal of Cancer56 citations Open access
Semantic Scholar
Overcoming enzalutamide resistance in metastatic prostate cancer by targeting sphingosine kinase
Hui-Ming Lin, B. Mak, N. Yeung, K. Huynh +25 more
2021EBioMedicine51 citations Open access
Semantic Scholar
Adjuvant chemotherapy for early colon cancer: what survival benefits make it worthwhile?
P. Blinman, V. Duric, A. Nowak, P. Beale +6 more
2010European Journal of Cancer41 citations
Semantic Scholar
OA08.02 DREAM - A Phase 2 Trial of Durvalumab with First Line Chemotherapy in Mesothelioma: Final Result
A. Nowak, Peey-Sei Kok, W. Lesterhuis, B. Hughes +11 more
2018Journal of Thoracic Oncology40 citations Open access
Semantic Scholar
Oral Cannabis Extract for Secondary Prevention of Chemotherapy-Induced Nausea and Vomiting: Final Results of a Randomized, Placebo-Controlled, Phase II/III Trial
P. Grimison, Antony J. Mersiades, Adrienne Kirby, A. Tognela +20 more
2024Journal of Clinical Oncology29 citations Open access
Semantic Scholar
Combined impact of lipidomic and genetic aberrations on clinical outcomes in metastatic castration-resistant prostate cancer
B. Mak, Hui-Ming Lin, E. Kwan, Heidi Fettke +23 more
2022BMC Medicine22 citations Open access
Semantic Scholar
Melanoma and immunotherapy bridge 2015
V. Nanda, Weiyi Peng, P. Hwu, M. Davies +384 more
2016Journal of Translational Medicine22 citations Open access
Semantic Scholar
First-Line, Fixed-Duration Nivolumab Plus Ipilimumab Followed by Nivolumab in Clinically Diverse Patient Populations With Unresectable Stage III or IV Melanoma: CheckMate 401
R. Dummer, P. Corrie, R. Gutzmer, T. Meniawy +22 more
2023Journal of Clinical Oncology21 citations Open access
Semantic Scholar
Immunotherapy-related gastritis: Two case reports and literature review
R. Woodford, K. Briscoe, R. Tustin, Ankit Jain
2021Clinical Medicine Insights: Oncology20 citations Open access
Semantic Scholar
Oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting: a study protocol for a pilot and definitive randomised double-blind placebo-controlled trial (CannabisCINV)
Antony J. Mersiades, A. Tognela, P. Haber, M. Stockler +16 more
2018BMJ Open19 citations Open access
Semantic Scholar
Relationship between Circulating Lipids and Cytokines in Metastatic Castration-Resistant Prostate Cancer
Hui-Ming Lin, N. Yeung, Jordan F. Hastings, D. Croucher +17 more
2021Cancers16 citations Open access
Semantic Scholar
Pamiparib in combination with tislelizumab in patients with advanced solid tumours: results from the dose-expansion stage of a multicentre, open-label, phase I trial
M. Friedlander, L. Mileshkin, J. Lombard, S. Frentzas +11 more
2023British Journal of Cancer15 citations Open access
Semantic Scholar
Clinical validation of circulating GDF15/MIC‐1 as a marker of response to docetaxel and survival in men with metastatic castration‐resistant prostate cancer
K. Mahon, Sarah Sutherland, Hui-Ming Lin, M. Stockler +11 more
2024The Prostate12 citations Open access
Semantic Scholar
Systemic Bacillus Calmette‐Guerin sepsis manifesting as hypercalcaemia and thrombocytopenia as a complication of intravesical Bacillus Calmette‐Guerin therapy
N. Nayar, K. Briscoe
2015Internal medicine journal (Print)8 citations
Semantic Scholar
Cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting: Results of a phase II/III, placebo-controlled, randomised trial.
Antony J. Mersiades, Adrienne Kirby, M. Stockler, A. Tognela +16 more
2023Journal of Clinical Oncology4 citations Open access
Semantic Scholar
Pilot and definitive randomised double-blind placebo-controlled trials evaluating an oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting (CINV).
Antony J. Mersiades, A. Tognela, P. Haber, M. Stockler +16 more
2018Annals of Oncology4 citations Open access
Semantic Scholar
EviQ cancer treatments online (www.eviQ.org.au): A widely used Australian resource.
L. Loke, R. Ward, Jane Garrad, K. Faulkner +14 more
20144 citations
Semantic Scholar
MONARCC: a randomised phase II study of panitumumab monotherapy and panitumumab plus 5-fluorouracil as first-line therapy for RAS and BRAF wildtype metastatic colorectal cancer: a study by the Australasian Gastrointestinal Trials Group (AGITG)
H. Siu, N. Tebbutt, L. Chantrill, C. Karapetis +20 more
2021BMC Cancer3 citations Open access
Semantic Scholar
Pilot and definitive randomised double-blind placebo-controlled trials evaluating an oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting (CINV).
Antony J. Mersiades, A. Tognela, P. Haber, M. Stockler +16 more
20183 citations
Semantic Scholar
1245PA PHASE 3 RANDOMISED TRIAL OF ADDING NITROGLYCERIN TO FIRST LINE CHEMOTHERAPY FOR ADVANCED NON-SMALL CELL LUNG CANCER: THE AUSTRALASIAN LUNG CANCER TRIALS GROUP NITRO TRIAL.
A. Davidson, A. Veillard, A. Tognela, M. Chan +10 more
2014Annals of Oncology3 citations Open access
Semantic Scholar
Clinical validation of circulating cytokines as markers of prognosis and response to docetaxel in men with metastatic castration-resistant prostate cancer.
K. Mahon, Hui-Ming Lin, M. Lee-Ng, M. Stockler +10 more
2019Journal of Clinical Oncology2 citations
Semantic Scholar
Oncologists' estimates of expected survival time and scenarios for survival: accuracy in the ALTG NITRO trial of 1st line chemotherapy for advanced non–small-cell lung cancer.
A. Tognela, D. Espinoza, A. Davidson, M. Chan +10 more
20162 citations
Semantic Scholar
Phase II trial of circulating cytokines as markers of docetaxel (DTX) resistance in metastatic castrate-resistant prostate cancer (mCRPC).
K. Mahon, Hui-Ming Lin, C. Spielman, M. Lee-Ng +8 more
20161 citations
Semantic Scholar
MAGMA: Multi-arm glioblastoma Australasia phase 3 trial.
C. Gedye, K. Cuff, P. Lau, A. Dowling +16 more
2026Journal of Clinical Oncology0 citations
Semantic Scholar
Efficacy of programmed cell death protein 1 (PD1) inhibitors in cutaneous squamous cell carcinoma (cSCC) patients with large nerve-perineural invasion (LN-PNI): A multicenter retrospective study.
P. Shrestha, R. Ladwa, G. Heller, T. Low +8 more
2022Journal of Clinical Oncology0 citations
Semantic Scholar
596P Impact of combined lipidomic and genetic aberrations on clinical outcomes in metastatic castration-resistant prostate cancer (mCRPC)
B. Mak, H. Lin, E. Kwan, Heidi Fettke +16 more
2021Annals of Oncology0 citations Open access
Semantic Scholar
635P Association of ceramide metabolism with resistance to androgen receptor signalling inhibitors in metastatic prostate cancer
H. Lin, B. Mak, K. Huynh, E. Kwan +15 more
2021Annals of Oncology0 citations Open access
Semantic Scholar
Final Results of the Dream Trial: A Phase 2 Trial of Durvalumab with First-Line Chemotherapy in Mesothelioma with a Safety Run-In
A. Nowak, W. Lesterhuis, Peey-Sei Kok, Chris Brown +14 more
20200 citations
Semantic Scholar
Results of crossover phase II component of randomized placebo-controlled trial evaluating oral THC/cannabis extract for refractory chemotherapy-induced nausea and vomiting (CINV).
P. Grimison, M. Stockler, Adrienne Kirby, A. Walsh +16 more
20200 citations
Semantic Scholar
Clinical validation of circulating cytokines as markers of prognosis and response to docetaxel in men with metastatic castration resistant prostate cancer
K. Mahon, Hm Lin, M. Lee-Ng, D. Cain +12 more
2019Oncology Abstracts0 citations
Semantic Scholar
The plasma lipidome in castration-resistant prostate cancer.
L. Horvath, Hui-Ming Lin, K. Mahon, J. Weir +11 more
20170 citations
Semantic Scholar
ANZUP Annual Scientific Meeting, The Art & Science of Best Practice, 16-18 July 2017, Pullman Albert Park, Melbourne, VIC, Australia.
L. Horvath, Hui-Ming Lin, K. Mahon, J. Weir +11 more
2017Asia-Pacific Journal of Clinical Oncology0 citations
Semantic Scholar
Melanoma and immunotherapy bridge 2015
V. Nanda, Weiyi Peng, P. Hwu, M. Davies +386 more
2016Journal of Translational Medicine0 citations Open access
Semantic Scholar
A case of cutaneous metastasis of the scalp from colorectal adenocarcinoma.
M. Tran, V. Lea, K. Briscoe
2016Pathology (Sydney)0 citations
Semantic Scholar
Neutropenic fever rates with adjuvant docetaxel and cyclophosphamide in early breast cancer: audit from regional cancer centre in New South Wales
A. Jain, J. Linsell, K. Briscoe
2014Internal medicine journal (Print)0 citations
Semantic Scholar
Patients’ preferences for adjuvant chemotherapy (ACT) in early colon cancer (ECC): What makes it worthwhile?
P. Blinman, V. Duric, A. Nowak, P. Beale +6 more
20080 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Stockler×26
Invite
M. Stockler — researcher profile on SciRah
K. Mahon×12
Invite
K. Mahon — researcher profile on SciRah
G. Marx×12
Invite
G. Marx — researcher profile on SciRah
L. Horvath×11
Invite
L. Horvath — researcher profile on SciRah

×10

Invite

Hui-Ming Lin — researcher profile on SciRah

Invite

A. Tognela — researcher profile on SciRah

G. Mallesara×8

Invite

G. Mallesara — researcher profile on SciRah

Invite

P. Meikle — researcher profile on SciRah

Invite

P. Grimison — researcher profile on SciRah

Antony J. Mersiades×7

Invite

Antony J. Mersiades — researcher profile on SciRah

Invite

H. Gurney — researcher profile on SciRah

Invite

N. Pavlakis — researcher profile on SciRah